CHX-3107

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCHX-3107
Drug Alias NameEPC-K1CHX-3107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid peroxidation inhibitorsAngiotensin-converting enzyme inhibitorsImmunosuppressants
TargetsAngiotensin-converting enzyme
Therapy Area/IndicationsReperfusion InjuryStrokeCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSenju Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSenju Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryStrokeCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A